在肺癌中经手术期免疫疗法的最新进展
Shota Fukuda1, Kenichi Suda1, Akira Hamada1
1Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osakasayama 589-8511, Japan.
Biomolecules
|September 28, 2023
概括
术后免疫疗法,包括编程死亡1 (PD-1) 和PD-L1抑制剂,正在改变早期非小细胞肺癌 (NSCLC) 治疗. 目前正在进行的试验正在探索这些新型免疫疗法的最佳时间和患者选择.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胸部外科手术 胸部外科手术
背景情况:
- 早期非小细胞肺癌 (NSCLC) 治疗正在与外科手术期间的免疫疗法一起发展.
- 针对编程死亡1 (PD-1) 的免疫检查点抑制剂及其连接物PD-L1是这些进展的核心.
研究的目的:
- 审查和综合近期临床试验中关于治疗早期NSCLC的术后免疫疗法的数据.
- 解决有关最佳时间 (新辅助剂,辅助剂或两者) 和免疫治疗患者选择的关键临床问题.
主要方法:
- 包括IMpower010,CheckMate816,AEGEAN,KEYNOTE-671,NADIM II和Neotorch在内的关键临床试验的已公布数据的全面审查.
- 分析与NSCLC免疫疗法的疗效,安全性和患者分层相关的发现.
主要成果:
- 辅助剂阿特佐利祖马布,新辅助剂尼沃卢马布加化疗,以及各种外科手术期间的免疫疗法已经证明了有效性.
- 关于最佳治疗顺序和患者选择以最大限度地提高益处并最大限度地减少与免疫相关的不良事件,仍然存在重要的临床问题.
结论:
- 周围手术免疫疗法在彻底改变早期NSCLC治疗方面表现有前途.
- 进一步的研究和对正在进行的试验的全面了解对于完善治疗策略和改善患者治疗结果至关重要.
关键词:
在ICI组合疗法和ICI组合疗法.作为辅助治疗的辅助治疗.生物标志物生物标志物作为一种新辅助治疗,新辅助治疗.非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.编程细胞死亡连接物1 (PD-L1)迁移阶段迁移阶段的迁移.更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
17.1K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
01:30Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K